Related Experiment Video
Updated: Jul 22, 2026
11:31
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
Screening for lung cancer. The Mayo Lung Project revisited
B J Flehinger1, M Kimmel, T Polyak
1Mathematical Sciences Department, T. J. Watson Research Center, Yorktown Heights, New York 10598.
Cancer
|September 1, 1993
Summary
The Mayo Lung Project found no mortality benefit from frequent lung cancer screening after 6 years. Long-term annual screening may offer a modest mortality decrease, but improved detection and treatment are key.
Area of Science:
- Oncology
- Public Health
- Biostatistics
Background:
- The Mayo Lung Project (MLP) evaluated lung cancer screening using chest radiographs and sputum cytology every 4 months versus annual screening.
- No significant mortality benefit was observed in the MLP after 6 years of follow-up.
Purpose of the Study:
- To estimate parameters for a mathematical model of lung cancer natural history using Mayo data.
- To assess the potential benefits of periodic lung cancer screening for high-risk individuals starting at age 45.
Main Methods:
- A simulation study was conducted using data from the Mayo Lung Project.
- Mathematical modeling was employed to analyze lung cancer progression and screening efficacy.
Main Results:
- The mean duration of Stage I non-small cell lung cancer was found to be at least 4 years.
- Stage I lung cancer detectability and curability rates were estimated to be less than 25% and 35%, respectively.
Conclusions:
- The MLP trial likely had insufficient power to demonstrate significant screening benefits.
- Long-term annual screening might yield a modest reduction in lung cancer mortality (0-13%).
- Enhanced early detection and treatment strategies hold greater potential for improving lung cancer outcomes.
